Modifications of the GSK3β substrate sequence to produce substrate-mimetic inhibitors of Akt as potential anti-cancer therapeutics

Katherine J. Kayser, Matthew P. Glenn, Said M. Sebti, Jin Q. Cheng, Andrew D. Hamilton

Research output: Contribution to journalArticle

Abstract

Amplification, overexpression, and elevated activation of Akt have been detected in many human malignancies making it an important target for cancer therapy. The Akt substrate-binding site offers a large number of potential interactions to an appropriately designed small molecule and can form the basis for the development of selective inhibitors. Here, we report the progression of GSK3β substrate-mimetic inhibitors towards the development of a potent, small molecule substrate-mimetic inhibitor of Akt.

Original languageEnglish (US)
Pages (from-to)2068-2073
Number of pages6
JournalBioorganic and Medicinal Chemistry Letters
Volume17
Issue number7
DOIs
StatePublished - Apr 1 2007

Keywords

  • Akt
  • Cancer
  • Peptidomimetics
  • Protein kinase B
  • Substrate-mimetic

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmaceutical Science
  • Drug Discovery
  • Clinical Biochemistry
  • Organic Chemistry

Fingerprint Dive into the research topics of 'Modifications of the GSK3β substrate sequence to produce substrate-mimetic inhibitors of Akt as potential anti-cancer therapeutics'. Together they form a unique fingerprint.

  • Cite this